Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

31 results about "Salmonella antibody" patented technology

Non-diagnostic purpose method for quantitatively detecting Salmonella pullorum and Salmonella gallinarum

The invention discloses a non-diagnostic purpose method for rapidly detecting Salmonella pullorum and Salmonella gallinarum. The detection method comprises the following steps: preparing Salmonella pullorum and Salmonella gallinarum antibody labeled coupled magnetic nano-particles (IgG-MNPs) and antibody and enzyme double labeled silica nano-particles (GOx-IgG-SiNPs), forming an immune compound IgG-MNPs/S having a sandwich structure, S. Pullorum and S. Gallinarum GOx-IgG-SiNPs, when the target bacteria to be detected exist, performing an enzymatically catalyzed reaction, allowing the obtainedreaction product and a color developer to form a complex product, and detecting the absorbance value of the obtained system to obtain the concentrations of the Salmonella pullorum and Salmonella gallinarum in order to realize the quantitative detection of the Salmonella pullorum and Salmonella gallinarum. A cascade reaction triggered by glucose oxidase (GOx) is combined with an Fe<3+>-SCN<-> colordevelopment system to realize the quantitative detection of Salmonella pullorum and Salmonella typhimurium. The detection method has the advantages of convenience, fastness, easiness in operation, good sensitivity, good specificity and good stability.
Owner:ZHEJIANG GONGSHANG UNIVERSITY

Preparation method and application of salmonella inactivated vaccine

The invention discloses a preparation method and application of a salmonella pullorum gene mutant strain inactivated vaccine. The preparation method comprises the steps that a lambda-Red system is used for preparing a salmonella pullorum pagC gene deletion mutant strain delta PagC; delta PagC bacterial liquid cultured overnight is taken and inoculated into 50ml of a liquid LB culture medium according to a ratio of 1:100, and shaking culture is conducted at 37 DEG C and 180rpm until an OD value is about 0.8; a formaldehyde solution with the final concentration of 0.4% is added, shaking cultureis continuously conducted for 16 hours, centrifuging is conducted for 10 minutes at the temperature of 4 DEG C and the speed of 5000rpm, and thalli are collected, washed with a sterile PBS buffer solution, and resuspended for three times to obtain a stock solution; the dosage is adjusted, the stock solution is mixed with an adjuvant according to a ratio of 1:1, fully emulsifying is conducted, andthen the inactivated vaccine is inoculated to animals. By preparing the salmonella inactivated vaccine, no adverse reaction is caused after the vaccine strain is inoculated to a mouse, and the mouse can be protected against infection of salmonella pullorum CVCC1800, salmonella enteritidis ATCC19585 and salmonella typhimurium CVCC542. The vaccine can be used in combination with a salmonella antibody indirect ELISA detection kit based on PagC protein, differential diagnosis of salmonella artificial immunity and natural infection is achieved, and good DIVA characteristics are shown.
Owner:NANJING AGRICULTURAL UNIVERSITY

Method for simultaneously purifying and detecting avian leukosis and avian salmonellosis by utilizing one hatching egg and application of method

The invention belongs to the field of animal husbandry and veterinary and in particular relates to a method for simultaneously purifying and detecting avian leukosis and avian salmonellosis by utilizing one hatching egg and application of the method. The method comprises the following steps: feeding breeder flocks in single cages and encoding; collecting primary hatching eggs of the breeder flocks; enabling the primary hatching eggs to correspond to numbers of the hatching eggs one by one; disinfecting the surfaces of the hatching eggs and opening egg shells from hatching egg air chamber ends;sucking egg white and yolks and putting into PE (Polyethylene) tubes respectively and marking; putting egg white and yolk samples into a refrigerator and freezing and thawing for a plurality of times; taking the frozen and thawed egg white; detecting an ALV virus antigen through an avian leukosis ELISA (Enzyme Linked Immunosorbent Assay) detection method; taking the frozen and thawed yolks and adding normal saline and chloroform; after uniformly mixing on an oscillator, centrifuging and layering a solution, wherein a lower layer is an organic solvent, a middle layer is denatured lipid proteinand an upper layer is an extracted antibody; and sucking the antibody of the upper layer and detecting a salmonellosis antibody through a plate agglutination method; and eliminating chicken flock individuals with positive detection results of the ALV virus antigen and the salmonellosis antibody.
Owner:INST OF ANIMAL SCI & VETERINARY HUBEI ACADEMY OF AGRI SCI

Pullorum disease antibody latex agglutination negative selection detection kit as well as preparation method and application thereof

ActiveCN106706904AQuick checkGet rid of mutationMaterial analysisAntigenInstability
The invention discloses a pullorum disease antibody latex agglutination negative selection detection kit, comprising a salmonella surface protein InvJ recombinant protein sensitized latex reagent and a secreted protein SopA C-terminal recombinant protein sensitized latex reagent, wherein the InvJ recombinant protein sensitized latex reagent can rapidly detect a salmonella antibody by virtue of a latex agglutination test, the SopA C-terminal recombinant protein sensitized latex reagent can detect serotype salmonella antibodies except for the pullorum disease by virtue of the latex agglutination test, and the combination of the two reagents is used for negative selection of a pullorum disease antibody positive blood or serum sample. The invention also discloses a preparation method of salmonella surface protein InvJ recombinant protein and secreted protein SopA C-terminal recombinant protein sensitized latex reagents. The pullorum disease antibody latex agglutination negative selection detection kit disclosed by the invention has the advantages of stable antigen, strong specificity and high sensitivity, and solves the problem of antigen instability caused by potential variability and changed culture conditions of an existing pullorum disease agglutination antigen production strain.
Owner:INST OF ANIMAL SCI & VETERINARY HUBEI ACADEMY OF AGRI SCI

Pullorum antibody latex agglutination negative screening kit, preparation method and application

ActiveCN106706904BQuick checkAntigen stabilizationMaterial analysisAntigenSerum ige
The invention discloses a pullorum disease antibody latex agglutination negative selection detection kit, comprising a salmonella surface protein InvJ recombinant protein sensitized latex reagent and a secreted protein SopA C-terminal recombinant protein sensitized latex reagent, wherein the InvJ recombinant protein sensitized latex reagent can rapidly detect a salmonella antibody by virtue of a latex agglutination test, the SopA C-terminal recombinant protein sensitized latex reagent can detect serotype salmonella antibodies except for the pullorum disease by virtue of the latex agglutination test, and the combination of the two reagents is used for negative selection of a pullorum disease antibody positive blood or serum sample. The invention also discloses a preparation method of salmonella surface protein InvJ recombinant protein and secreted protein SopA C-terminal recombinant protein sensitized latex reagents. The pullorum disease antibody latex agglutination negative selection detection kit disclosed by the invention has the advantages of stable antigen, strong specificity and high sensitivity, and solves the problem of antigen instability caused by potential variability and changed culture conditions of an existing pullorum disease agglutination antigen production strain.
Owner:INST OF ANIMAL SCI & VETERINARY HUBEI ACADEMY OF AGRI SCI

Preparation method and screening method of salmonella PagC protein monoclonal antibody

The invention discloses a preparation method and a screening method of a salmonella PagC protein monoclonal antibody. The preparation method comprises the following steps of immunizing Balb/c mice byusing purified PagC protein, and obtaining six hybridoma cells capable of producing an anti-PagC protein monoclonal antibody according to a hybridoma cell preparation technology; and synthesizing intergeneric specific amino acid sequences DRQASGSVEPEGIH(P1) and FKEHSTQDGDSFNKISSRKTGFA(P2) containing linear epitopes as screening antigens to obtain a monoclonal antibody cell strain J of which the antigen epitopes are on a linear P1 sequence, wherein the other five monoclonal antibody epitopes are not on linear P1 and P2 amino acid sequences. Western-blotting results show that mAb J can react with purified PagC protein, wild type pullorum disease and mouse typhoid fever PagC protein and does not react with other enterobacteriaceae PagC protein, and it is shown that the screened mAb J epitopeP1 is conservative in salmonella and is intergeneric specific. By preparing the monoclonal antibody, a salmonella antibody blocking ELISA detection method can be established, and the monoclonal antibody has the characteristics of good specificity and high sensitivity and has wide popularization potential.
Owner:NANJING AGRICULTURAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products